DRW Securities’s Eiger BioPharmaceuticals, Inc. EIGR Stock Holding History

DRW Securities’s Portfolio EIGR Stock Details EIGR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q4	–	Sell	-4,012	Closed	-$37K	–	474
2023 Q3	$37K	Hold	4,012	–	–	﹤0.01%	331
2023 Q2	$85K	Hold	4,012	–	–	﹤0.01%	316
2023 Q1	$108K	Hold	4,012	–	–	﹤0.01%	303
2022 Q4	$142K	Hold	4,012	–	–	﹤0.01%	244
2022 Q3	$906K	Hold	4,012	–	–	0.02%	121
2022 Q2	$758K	Hold	4,012	–	–	0.02%	125
2022 Q1	$999K	Hold	4,012	–	–	0.03%	128
2021 Q4	$625K	Hold	4,012	–	–	0.02%	123
2021 Q3	$804K	Hold	4,012	–	–	0.03%	120
2021 Q2	$1.03M	Hold	4,012	–	–	0.03%	127
2021 Q1	$1.06M	Hold	4,012	–	–	0.04%	84
2020 Q4	$1.48M	Sell	4,012 -1,000	-20%	-$287K	0.05%	65
2020 Q3	$1.22M	Buy	5,012 +1,333	+36%	+$415K	0.07%	68
2020 Q2	$1.06M	Hold	3,679	–	–	0.05%	81
2020 Q1	$750K	Hold	3,679	–	–	0.03%	108
2019 Q4	$1.64M	Hold	3,679	–	–	0.06%	69
2019 Q3	$1.13M	Buy	3,679 +1,346	+58%	+$437K	0.08%	70
2019 Q2	$742K	Buy	+2,333	New	+$808K	0.04%	58
2019 Q1	–	Sell	-825	Closed	-$251K	–	112
2018 Q4	$251K	Buy	825 +333	+68%	+$108K	0.01%	52
2018 Q3	$177K	Sell	492 -145	-23%	-$49.6K	0.01%	43
2018 Q2	$233K	Buy	637 +104	+20%	+$37K	0.01%	63
2018 Q1	$158K	Buy	+533	New	+$157K	0.01%	133

Other funds holding EIGR

Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return

PBM

Propel Bio Management Los Angeles, California $159M AUM 60.94% 1-Year Est. Return

6CM

683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

RBF Capital San Francisco, California $2.05B AUM 29.64% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

DRW Securities's EIGR Position: Q4 2023 in Review

DRW Securities sold out of Eiger BioPharmaceuticals, Inc. (EIGR) in Q4 2023, closing a stake of 4,012 shares — an estimated $37K sold.

DRW Securities first reported a position in EIGR in Q1 2018 and held it in 22 quarters. The position peaked at $1.64M in Q4 2019. 43 funds tracked by Wall St. Rank hold EIGR as of Q4 2023.

DRW Securities reported no remaining Eiger BioPharmaceuticals, Inc. position as of Q4 2023 after selling out during the quarter.
DRW Securities sold 4,012 Eiger BioPharmaceuticals, Inc. shares in Q4 2023, an estimated $37K.
DRW Securities first reported a position in Eiger BioPharmaceuticals, Inc. in Q1 2018 and held it in 22 quarters.
DRW Securities's Eiger BioPharmaceuticals, Inc. position peaked at $1.64M in Q4 2019.
43 funds tracked by Wall St. Rank held Eiger BioPharmaceuticals, Inc. as of Q4 2023.

Based on DRW Securities's 13F filing for Q4 2023, filed 16 Feb 2024.